(Q50894046)

24 March 2018

title

Changing trend in bile microbiology and antibiotic susceptibilities: over 12 years of experience. (English)

1 reference

24 March 2018

author name string

W Kwon

1

1 reference

24 March 2018

J-Y Jang

2

1 reference

24 March 2018

E-C Kim

3

1 reference

24 March 2018

J W Park

4

1 reference

24 March 2018

I W Han

5

1 reference

24 March 2018

M J Kang

6

1 reference

24 March 2018

S-W Kim

7

1 reference

24 March 2018

publication date

21 November 2012

1 reference

24 March 2018

published in

Infection

1 reference

24 March 2018

volume

41

1 reference

24 March 2018

issue

1

1 reference

24 March 2018

page(s)

93-102

1 reference

24 March 2018

https://api.crossref.org/works/10.1007%2FS15010-012-0358-Y

1 reference

Gallbladder bacteriology, histology, and gallstones. Study of unselected cholecystectomy specimens in Honolulu.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0358-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0358-Y

Bacteriological study of transhepatically aspirated bile. Relation to cholangiographic findings in 295 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0358-Y

Biliary tract infection and bacteraemia: presentation, structural abnormalities, causative organisms and clinical outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0358-Y

Microbiology and antibiotic susceptibility of organisms in bile cultures from patients with and without cholangitis at an Asian academic medical center.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0358-Y

Bile bacterial flora and its in vitro resistance pattern in patients with acute cholangitis resulting from choledocholithiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0358-Y

Microbiology of choledochal bile in patients with choledocholithiasis admitted to a tertiary hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0358-Y

Microbial profile and antibiotic sensitivity pattern in acute bacterial cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0358-Y

Microbiology of bile in patients with cholangitis or cholestasis with and without plastic biliary endoprosthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0358-Y

Resistant pathogens in biliary obstruction: importance of cultures to guide antibiotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0358-Y

Enterococcal bactibilia in patients with malignant biliary obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0358-Y

Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia--a five-year retrospective review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0358-Y

Major trends in the microbial etiology of nosocomial infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0358-Y

High-level penicillin resistance among isolates of enterococci. Implications for treatment of enterococcal infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0358-Y

Emergence of vancomycin-resistant enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0358-Y

Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0358-Y

A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0358-Y

An analysis of infectious failures in acute cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0358-Y

Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0358-Y

Are there patients with peritonitis who require empiric therapy for enterococcus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0358-Y

Gangrenous cholecystitis and acute cholangitis associated with anaerobic bacteria in bile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0358-Y

Routine bile collection for microbiological analysis during cholangiography and its impact on the management of cholangitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0358-Y

Antimicrobial therapy for acute cholangitis: Tokyo Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0358-Y

Comparison of Intravenous/Oral Ciprofloxacin Plus Metronidazole Versus Piperacillin/Tazobactam in the Treatment of Complicated Intraabdominal Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0358-Y

Microbiologic study of the bile culture and antimicrobial susceptibility in patients with biliary tract infection

21 January 2018

1 reference

12 December 2020

High-level gentamicin resistance in Enterococcus: microbiology, genetic basis, and epidemiology

1 reference

12 December 2020

Attributable mortality rate and duration of hospital stay associated with enterococcal bacteremia

1 reference

12 December 2020

Bacteriological study of choledochal bile in patients with common bile duct stones, with or without acute suppurative cholangitis.

1 reference

12 December 2020

Prospective randomized study of piperacillin/tazobactam therapy of surgically treated intra-abdominal infection. The Piperacillin/Tazobactam Intra-Abdominal Infection Study Group.

1 reference

12 December 2020

Role of antibiotics in the treatment and prevention of acute and recurrent cholangitis.

1 reference

12 December 2020

1 reference

12 December 2020

Efficacy of a beta-lactamase inhibitor combination for serious intraabdominal infections

1 reference

12 December 2020

Clogging of Biliary Endoprostheses: A Morphologic and Bacteriologic Study

1 reference

12 December 2020

A randomized trial of ticarcillin and clavulanate versus gentamicin and clindamycin in patients with complicated appendicitis

1 reference

12 December 2020

Piperacillin/tazobactam compared with cefuroxime/ metronidazole in the treatment of intra-abdominal infections

1 reference

12 December 2020

Mortality associated with enterococcal bacteremia

1 reference

12 December 2020

Bile culture and susceptibility testing of malignant biliary obstruction via PTBD

1 reference

12 December 2020

Bacteribilia and cholangitis after percutaneous transhepatic biliary drainage for malignant biliary obstruction

1 reference

12 December 2020

Antibiotics, biliary sepsis, and bile duct stones.

1 reference

12 December 2020

The role of Pseudomonas species in patients treated with ampicillin and Sulbactam for gangrenous and perforated appendicitis.

1 reference

12 December 2020

[A clinical study of bile cultures and antibiotic susceptibility test in the patients with operation on biliary tract].

1 reference

12 December 2020

10.1007/S15010-012-0358-Y

Identifiers

DOI

1 reference

24 March 2018

1 reference

24 March 2018